Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 2 |
2002 | 1 |
2003 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination.
Gene Ther. 2003 Aug;10(16):1311-20. doi: 10.1038/sj.gt.3301982.
Gene Ther. 2003.
PMID: 12883527
Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen.
Hung CF, He L, Juang J, Lin TJ, Ling M, Wu TC.
Hung CF, et al.
J Virol. 2002 Mar;76(6):2676-82. doi: 10.1128/jvi.76.6.2676-2682.2002.
J Virol. 2002.
PMID: 11861834
Free PMC article.
Item in Clipboard
Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen.
Hung CF, Cheng WF, Hsu KF, Chai CY, He L, Ling M, Wu TC.
Hung CF, et al.
Cancer Res. 2001 May 1;61(9):3698-703.
Cancer Res. 2001.
PMID: 11325841
Item in Clipboard
Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen.
Hung CF, Cheng WF, Chai CY, Hsu KF, He L, Ling M, Wu TC.
Hung CF, et al.
J Immunol. 2001 May 1;166(9):5733-40. doi: 10.4049/jimmunol.166.9.5733.
J Immunol. 2001.
PMID: 11313416
Item in Clipboard
Cite
Cite